文献速递儿科影像技术与安全US

危重儿科患者静脉注射超声造影剂

Intravenous administration of ultrasound contrast to critically ill pediatric patients.
PubMed 文献 · Pediatr Radiol · 2024-03-20

本回顾性研究纳入38例在新生儿、儿科或儿科心脏重症监护病房密切监测的危重患者(2天至17岁),共完成47次静脉超声造影检查,未发现与造影剂给药相关的呼吸、神经、心脏、灌注或生命体征的显著变化。

要点

  • 危重新生儿至青少年静脉注射超声造影剂后未观察到显著临床不良反应。
  • 监测指标包括生命体征及心肺、神经、血流动力学参数,给药前后均无显著变化。
  • 47次检查中包括有心脏分流或动脉导管未闭、呼吸衰竭、血流动力学不稳定等合并症者。

核心结论

  • 本研究回顾性未发现危重新生儿、婴儿、儿童及青少年静脉注射超声造影剂相关的任何不良临床效应。

研究设计与样本

  • 回顾性研究,纳入38例在新生儿、儿科或儿科心脏重症监护病房密切监测的危重患者,共完成47次超声造影检查,年龄2天至17岁,女性19例(50%),有早产史19例(50%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The off-label use of contrast-enhanced ultrasound has been increasingly used for pediatric patients.

OBJECTIVE: The purpose of this retrospective study is to report any observed clinical changes associated with the intravenous (IV) administration of ultrasound contrast to critically ill neonates, infants, children, and adolescents.

MATERIALS AND METHODS: All critically ill patients who had 1 or more contrast-enhanced ultrasound scans while being closely monitored in the neonatal, pediatric, or pediatric cardiac intensive care units were identified. Subjective and objective data concerning cardiopulmonary, neurological, and hemodynamic monitoring were extracted from the patient's electronic medical records. Vital signs and laboratory values before, during, and after administration of ultrasound contrast were obtained. Statistical analyses were performed using JMP Pro, version 15. Results were accepted as statistically significant for P-value<0.05.

RESULTS: Forty-seven contrast-enhanced ultrasound scans were performed on 38 critically ill patients, 2 days to 17 years old, 19 of which were female (50%), and 19 had history of prematurity (50%). At the time of the contrast-enhanced ultrasound scans, 15 patients had cardiac shunts or a patent ductus arteriosus, 25 had respiratory failure requiring invasive mechanical oxygenation and ventilation, 19 were hemodynamically unstable requiring continual vasoactive infusions, and 8 were receiving inhaled nitric oxide. In all cases, no significant respiratory, neurologic, cardiac, perfusion, or vital sign changes associated with IV ultrasound contrast were identified.

CONCLUSION: This study did not retrospectively identify any adverse clinical effects associated with the IV administration of ultrasound contrast to critically ill neonates, infants, children, and adolescents.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Riggs BJ, Martinez-Correa S, Stern J, et al. Intravenous administration of ultrasound contrast to critically ill pediatric patients. Pediatr Radiol. 2024. PMID: 38506945. doi:10.1007/s00247-024-05898-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。